Dr. Frank Critz is the founder and Medical Director of Radiotherapy Clinics of Georgia (RCOG). A leading authority on prostate cancer treatment, Dr. Critz has treated thousands of men with prostate cancer over the past 30 years. Knowing there had to be a better way to treat men with prostate cancer, Dr. Critz pioneered ProstRcision®, the prostate cancer treatment the highest documented cure rate of any prostate cancer treatment approach in the medical community.
As RCOG’s Director of Prostate Cancer Research, Dr. Critz has authored more than 70 peer-reviewed research papers that have been presented at major medical meetings or published in medical journals on prostate cancer. His ground-breaking research has contributed to the advancement of prostate cancer research world-wide.
Medical School:
University of Mississippi, 1965-1969
Residency:
Radiation Oncology, University of Mississippi and University of Florida, 1969-1973
Board Certification:
American Board of Radiology, Therapeutic Radiology, 1975
Military Service:
Brooks Army Medical Center, San Antonio, Texas: 1973-1975
Teaching Appointments:
Clinical Instructor of Radiation Oncology, University of Texas Medical Center, San Antonio, Texas, 1974-1975
Instructor, Radiation Oncology, Shands Teaching Hospital, Gainesville, Florida, 1975-1976
Medical License: Mississippi and Georgia
Certification & License:
American Board of Radiology, Therapeutic Radiology, Certified: 1975†¨
Professional Associations:
American Medical Association
DeKalb County Medical Society
Medical Association of Georgia
American Society of Therapeutic Radiology and Oncology
Association of Freestanding Radiation Oncology Centers
American Society of Clinical Oncology
American Brachytherapy Society
Dr. Critz practices at the main campus of Radiotherapy Clinics of Georgia, in Decatur.
Published articles by Dr. Critz’s.
Prostate Cancer Treated By Simultaneous Radiotherapy: I-125 Prostate Implant Followed By External-Beam Radiation
A.K. Levinson, F.A. Critz, V.D. Griffin. J Urol 159:63, 1998.
Cigarette Smoking Does Not Affect Treatment Results of Simultaneous Irradiation For Prostate Cancer
J.B. Benton, F.A. Critz, A.K. Levinson, F.J. Schnell, P.D. Shrake. ASCO Proceedings, 22:444, 2003.
Pretreatment Erectile Function Of Men Who Underwent Brachytherapy For Prostate Cancer
F.J. Schnell, F.A. Critz, J.B. Benton, P.D. Shrake. ASCO Proceedings, 22:444, 2003.
Probability of Achieving PSA Nadir 0.5 Ng/ml After Radiotherapy of Prostate Cancer
V.Griffin, F. Critz, K. Levinson, J. Benton. ASCO Proceedings, 18:339a, 1999.
Prostate Cancer in African-American Men Treated by Simultaneous Radiotherapy
F.Critz, K. Levinson, V. Griffin, J. Benton. ASCO Proceedings 18, 1999.
Prostate Specific Antigen Nadir After Brachytherapy for Prostate Cancer Correlates With Prognosis of Men Who Recur
Frank A. Critz, A. Keith Levinson, James B. Benton, Frederick J. Schnell, and Philip D. Shrake. J Urol 169 (supplement):179, 2003.
A Standard Definition of Disease Freedom is Needed for Prostate Cancer
F. Critz, J. Benton, F. Schnell, P. Shrake. American Brachytherapy Society Meeting. ABS Proceedings, 1:57, 2001.
Acute and Late Morbidity Following Simultaneous Irradiation for Prostate Cancer
F.A. Critz, K. Levinson, F. Schnell, J. Benton, P. Shrake. ASCO Proceedings, 20:189a, 2001.
Disease Free Survival Rates Following Irradiation of Prostate Cancer According to Age
J.B. Benton, F.A. Critz, F.J. Schnell, P.D. Shrake. ASCO Proceedings, 21:167B, 2002.
Sexual Function Following Simultaneous Irradiation for Prostate Cancer
F.A Critz, J.B. Benton, F.J. Schnell, P.D. Shrake. ASCO Proceedings, 21:188a, 2002.
Ten-Year Disease Free Survival Rate Calculated With PSA Cutpoint 0.2 ng/ml In Men After Brachytherapy For Prostate Cancer
F.A. Critz, A. Keith Levinson, J. B. Benton, F.J. Schnell, P.D. Shrake. J Urol 169 (supplement):181, 2003.
Treatment of Gleason Score 7 Prostate Cancer with I-125 Implant Followed by External Beam Radiotherapy
J. Benton, F.A. Critz, K. Levinson, V. Griffin. ASCO Proceedings, 18:317a, 1999.
Young Men with Prostate Cancer Treated by Simultaneous Radiotherapy
A. A. Sheikh, F.A. Critz, A.K. Levinson, J.B. Benton, F. Schnell, P. Shrake, L.S. Maxa. ASCO Proceedings, 19:227a, 2000.
Urinary Obstruction Following Brachytherapy Treatment of Prostate Cancer
F.A. Critz, A.A. Sheikh, P.D. Shrake, A.D. Levinson, J.B. Benton. ASCO Proceedings, 19:376a , 2000.
The PSA Nadir Goal for Radiotherapy of Prostate Cancer is GreaterThan or Less Than 0.2 NG/ML
F.A. Critz, A.K. Levinson, V.D. Griffin. J Urol 159:218, 1998.
Obstructive Uropathy Following Simultaneous Irradiation For Prostate Cancer Measured By A Longitudinal Study of The American Urological Association Symptom Index For Benign Prostate Hyperplasia
F.A. Critz, A. Keith Levinson, James B. Benton, F.J. Schnell, Philip D. Shrake. ABS Proceedings, 2:67, 2003.
Postirradiation Prostatitis: A Previously Unrecognized Syndrome Following Brachytherapy For Prostate Cancer
F.A. Critz, A.K. Levinson, J.B. Benton, F.J. Schnell, P.D. Shrake. ABS Proceedings, 2:66, 2003.
See all of RCOG’s published articles.
©2013 Vantage Oncology Company. All Rights Reserved.
Also known as Radiotherapy Clinics of Georgia (RCOG). Privacy Policy